CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Amgen Inc.’s disclosed that US regulators paused the study of an early-stage obesity drug, a lucrative market the company is trying to crack.

The Canadian and Mexican leaders negotiated with President Trump in diverging ways. In the end, they both secured an outcome ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

Along with the Sleepy Girl Mocktail, several other drinks are available that can help you get a good night's sleep. Here are ...

Once you turn 65, you’re generally entitled to Medicare coverage. But you don’t have to stick with original Medicare (Parts A ...

The U.S. Senate Committee on Finance was due to vote on Tuesday on advancing President Donald Trump's nominee for Secretary ...

Senate Majority Leader John Thune is playing dumb when it comes to Donald Trump’s significant efforts to shutter USAID. Since ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

If taking supplements is a part of your morning routine, you might just be popping them on auto-pilot without thinking twice ...

A shocking new investigation reveals that vapes laced with Spice and ketamine are making their way into classrooms ...